Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRaw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tg Therapeutics (TGTX) Current Assets (2016 - 2025)

Tg Therapeutics has reported Current Assets over the past 10 years, most recently at $630.8 million for Q4 2025.

  • Quarterly results put Current Assets at $630.8 million for Q4 2025, up 11.37% from a year ago — trailing twelve months through Dec 2025 was $630.8 million (up 11.37% YoY), and the annual figure for FY2025 was $630.8 million, up 11.37%.
  • Current Assets for Q4 2025 was $630.8 million at Tg Therapeutics, up from $599.8 million in the prior quarter.
  • Over the last five years, Current Assets for TGTX hit a ceiling of $664.0 million in Q2 2025 and a floor of $168.3 million in Q4 2022.
  • Median Current Assets over the past 5 years was $366.2 million (2021), compared with a mean of $397.4 million.
  • Biggest five-year swings in Current Assets: soared 507.86% in 2021 and later plummeted 55.49% in 2022.
  • Tg Therapeutics' Current Assets stood at $331.0 million in 2021, then plummeted by 49.16% to $168.3 million in 2022, then soared by 88.94% to $317.9 million in 2023, then soared by 78.13% to $566.4 million in 2024, then increased by 11.37% to $630.8 million in 2025.
  • The last three reported values for Current Assets were $630.8 million (Q4 2025), $599.8 million (Q3 2025), and $664.0 million (Q2 2025) per Business Quant data.